TrialEpilepsia2020

Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.

Andras Fogarasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.